Cytokinetics (CYTK) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Cytokinetics (CYTK) over the last 16 years, with Q4 2024 value amounting to $15.0 million.
- Cytokinetics' Non Operating Income rose 9791.72% to $15.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $51.5 million, marking a year-over-year increase of 8652.14%. This contributed to the annual value of $51.5 million for FY2024, which is 8652.14% up from last year.
- Per Cytokinetics' latest filing, its Non Operating Income stood at $15.0 million for Q4 2024, which was up 9791.72% from $17.1 million recorded in Q3 2024.
- Over the past 5 years, Cytokinetics' Non Operating Income peaked at $17.1 million during Q3 2024, and registered a low of -$377000.0 during Q4 2021.
- In the last 5 years, Cytokinetics' Non Operating Income had a median value of $3.1 million in 2020 and averaged $4.8 million.
- Its Non Operating Income has fluctuated over the past 5 years, first tumbled by 11756.76% in 2021, then skyrocketed by 169393.94% in 2022.
- Over the past 5 years, Cytokinetics' Non Operating Income (Quarter) stood at $2.1 million in 2020, then crashed by 117.57% to -$377000.0 in 2021, then skyrocketed by 1670.03% to $5.9 million in 2022, then increased by 28.16% to $7.6 million in 2023, then skyrocketed by 97.92% to $15.0 million in 2024.
- Its last three reported values are $15.0 million in Q4 2024, $17.1 million for Q3 2024, and $11.6 million during Q2 2024.